| NCT Number | NCT07741877 |
| Lead Sponsor | Iovance Biotherapeutics, Inc. |
| Conditions | Sarcoma, Soft Tissue Sarcoma (STS), Advanced Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS) |
| Enrollment | 80 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2033-09-01 (estimated) |
| Study Completion | 2034-09-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-03 |